Microsoft may represent a better model of balanced growth and land use decisions; by building without wrecking Juday Creek ...

Lecanemab received traditional approval in the U.S. in July 2023 for the treatment of early Alzheimer's disease (AD). This retrospective study was conducted to investigate the actual state of ...

Lecanemab presentations to include long-term Clarity AD data, real-world treatment insights, and a subcutaneous formulation ...

A new Alzheimer’s drug has been hailed as a major breakthrough after clinical trials showed it could clear the harmful brain ...

Community and research will remain priorities for the Alzheimer’s Association over the next 10 years, Maria Carrillo, PhD, ...

Amyloids are perhaps best known as a key driver of Alzheimer's disease.The amorphous proteins, found throughout the human ...

Four months after giving Eli Lilly’s Alzheimer’s disease treatment a thumbs-down, Europe’s Committee for Medicinal Products for Human Use (CHMP) has ...

Findings from the TRAILBLAZER-ALZ 2 long-term extension study highlight Kisunla continued to demonstrate slowing of decline, ...

Share on PinterestEating eggs regularly is linked to less buildup of toxic proteins in brain, according to a study on human ...

On July 1, $1 billion of cuts from the U.S. Department of Agriculture (USDA) took effect. The funding was for local schools ...

There are two types of people who support the Ride to END ALZ charity event: those directly impacted by Alzheimer’s and ones who hope never to be.